N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide

C137H143Cl4F2N25O19 — CID 159516897

IUPACN-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide
SMILESC=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CN4C)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CO4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)C4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)N4C)C1.Cc1c2c(cc3nc(NC(=O)c4ccccc4)n([C@@H]4CCCCN(C(=O)/C=C/CN5CCCC5)C4)c13)OC(F)(F)O2
InChIInChI=1S/C30H33F2N5O4.C27H29ClN6O3.C27H28ClN5O4.C27H27ClN4O4.C26H26ClN5O4/c1-20-26-23(18-24-27(20)41-30(31,32)40-24)33-29(34-28(39)21-10-3-2-4-11-21)37(26)22-12-5-6-17-36(19-22)25(38)13-9-16-35-14-7-8-15-35;1-4-22(36)33-11-6-5-10-18(14-33)34-25-19(13-20-24(23(25)28)30-21(35)15-32(20)3)29-27(34)31-26(37)17-9-7-8-16(2)12-17;1-4-21(34)32-11-6-5-10-18(14-32)33-24-19(13-20-25(23(24)28)37-15-22(35)31(20)3)29-27(33)30-26(36)17-9-7-8-16(2)12-17;1-3-22(34)31-10-5-4-9-19(14-31)32-24-21(13-18-12-20(33)15-36-25(18)23(24)28)29-27(32)30-26(35)17-8-6-7-16(2)11-17;1-3-21(34)31-10-5-4-9-17(13-31)32-24-18(12-19-23(22(24)27)29-20(33)14-36-19)28-26(32)30-25(35)16-8-6-7-15(2)11-16/h2-4,9-11,13,18,22H,5-8,12,14-17,19H2,1H3,(H,33,34,39);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,30,35)(H,29,31,37);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,29,30,36);3,6-8,11,13,19H,1,4-5,9-10,12,14-15H2,2H3,(H,29,30,35);3,6-8,11-12,17H,1,4-5,9-10,13-14H2,2H3,(H,29,33)(H,28,30,35)/b13-9+;;;;/t22-;2*18-;19-;17-/m11111/s1
InChIKeyMBHURTWWXNOCJH-VHYCOZIXSA-N
MW2623.61 g/mol
LogP22.66
Rot. Bonds22

About N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide

N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide (PubChem CID 159516897) has the molecular formula C137H143Cl4F2N25O19 and a molecular weight of 2623.61 g/mol. Its IUPAC name is N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide.

Molecular Properties

Compound NameN-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide
PubChem CID159516897
Molecular FormulaC137H143Cl4F2N25O19
Molecular Weight2623.61 g/mol
Exact Mass2619.97
IUPAC NameN-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide
SMILESC=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CN4C)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CO4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)C4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)N4C)C1.Cc1c2c(cc3nc(NC(=O)c4ccccc4)n([C@@H]4CCCCN(C(=O)/C=C/CN5CCCC5)C4)c13)OC(F)(F)O2
InChIInChI=1S/C30H33F2N5O4.C27H29ClN6O3.C27H28ClN5O4.C27H27ClN4O4.C26H26ClN5O4/c1-20-26-23(18-24-27(20)41-30(31,32)40-24)33-29(34-28(39)21-10-3-2-4-11-21)37(26)22-12-5-6-17-36(19-22)25(38)13-9-16-35-14-7-8-15-35;1-4-22(36)33-11-6-5-10-18(14-33)34-25-19(13-20-24(23(25)28)30-21(35)15-32(20)3)29-27(34)31-26(37)17-9-7-8-16(2)12-17;1-4-21(34)32-11-6-5-10-18(14-32)33-24-19(13-20-25(23(24)28)37-15-22(35)31(20)3)29-27(33)30-26(36)17-9-7-8-16(2)12-17;1-3-22(34)31-10-5-4-9-19(14-31)32-24-21(13-18-12-20(33)15-36-25(18)23(24)28)29-27(32)30-26(35)17-8-6-7-16(2)11-17;1-3-21(34)31-10-5-4-9-17(13-31)32-24-18(12-19-23(22(24)27)29-20(33)14-36-19)28-26(32)30-25(35)16-8-6-7-15(2)11-16/h2-4,9-11,13,18,22H,5-8,12,14-17,19H2,1H3,(H,33,34,39);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,30,35)(H,29,31,37);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,29,30,36);3,6-8,11,13,19H,1,4-5,9-10,12,14-15H2,2H3,(H,29,30,35);3,6-8,11-12,17H,1,4-5,9-10,13-14H2,2H3,(H,29,33)(H,28,30,35)/b13-9+;;;;/t22-;2*18-;19-;17-/m11111/s1
InChIKeyMBHURTWWXNOCJH-VHYCOZIXSA-N
XLogP22.66
TPSA484.36 Ų
H-Bond Donors7
H-Bond Acceptors31
Rotatable Bonds22
Heavy Atoms187
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002623.61
LogP ≤ 522.66
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide?
The IUPAC name of N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide (CID 159516897) is N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide.
What is the SMILES notation for N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide?
The canonical SMILES for N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide is C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CN4C)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)NC(=O)CO4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)C4)C1.C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C)c3)nc3cc4c(c(Cl)c32)OCC(=O)N4C)C1.Cc1c2c(cc3nc(NC(=O)c4ccccc4)n([C@@H]4CCCCN(C(=O)/C=C/CN5CCCC5)C4)c13)OC(F)(F)O2.
What is the InChIKey of N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide?
The InChIKey is MBHURTWWXNOCJH-VHYCOZIXSA-N. The full InChI is InChI=1S/C30H33F2N5O4.C27H29ClN6O3.C27H28ClN5O4.C27H27ClN4O4.C26H26ClN5O4/c1-20-26-23(18-24-27(20)41-30(31,32)40-24)33-29(34-28(39)21-10-3-2-4-11-21)37(26)22-12-5-6-17-36(19-22)25(38)13-9-16-35-14-7-8-15-35;1-4-22(36)33-11-6-5-10-18(14-33)34-25-19(13-20-24(23(25)28)30-21(35)15-32(20)3)29-27(34)31-26(37)17-9-7-8-16(2)12-17;1-4-21(34)32-11-6-5-10-18(14-32)33-24-19(13-20-25(23(24)28)37-15-22(35)31(20)3)29-27(33)30-26(36)17-9-7-8-16(2)12-17;1-3-22(34)31-10-5-4-9-19(14-31)32-24-21(13-18-12-20(33)15-36-25(18)23(24)28)29-27(32)30-26(35)17-8-6-7-16(2)11-17;1-3-21(34)31-10-5-4-9-17(13-31)32-24-18(12-19-23(22(24)27)29-20(33)14-36-19)28-26(32)30-25(35)16-8-6-7-15(2)11-16/h2-4,9-11,13,18,22H,5-8,12,14-17,19H2,1H3,(H,33,34,39);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,30,35)(H,29,31,37);4,7-9,12-13,18H,1,5-6,10-11,14-15H2,2-3H3,(H,29,30,36);3,6-8,11,13,19H,1,4-5,9-10,12,14-15H2,2H3,(H,29,30,35);3,6-8,11-12,17H,1,4-5,9-10,13-14H2,2H3,(H,29,33)(H,28,30,35)/b13-9+;;;;/t22-;2*18-;19-;17-/m11111/s1.
What are the key properties of N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide?
N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide has a molecular weight of 2623.61 g/mol, XLogP of 22.66, 22 rotatable bonds, 7 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-chloro-8-methyl-6-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-5,7-dihydroimidazo[4,5-g]quinoxalin-2-yl]-3-methylbenzamide;N-[4-chloro-8-methyl-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[9-chloro-7-oxo-1-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-imidazo[4,5-g][1,4]benzoxazin-2-yl]-3-methylbenzamide;N-[4-chloro-7-oxo-3-[(3R)-1-prop-2-enoylazepan-3-yl]-8H-pyrano[3,2-f]benzimidazol-2-yl]-3-methylbenzamide;N-[2,2-difluoro-8-methyl-7-[(3R)-1-[(E)-4-pyrrolidin-1-ylbut-2-enoyl]azepan-3-yl]-[1,3]dioxolo[4,5-f]benzimidazol-6-yl]benzamide is sourced from PubChem (CID 159516897), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).